BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 24782388)

  • 1. Comparison of moderate to severe systemic reactions with honeybee and wasp in children.
    Karagol HI; Bakirtas A; Yilmaz O; Topal E; Arga M; Demirsoy MS; Turktas I
    Int Forum Allergy Rhinol; 2014 Jul; 4(7):548-54. PubMed ID: 24782388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.
    Pereira Santos MC; Pedro E; Spínola Santos A; Branco Ferreira M; Palma Carlos ML; Palma Carlos AG
    Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):273-8. PubMed ID: 16285233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hymenoptera stings.
    Fitzgerald KT; Flood AA
    Clin Tech Small Anim Pract; 2006 Nov; 21(4):194-204. PubMed ID: 17265905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of specific immunotherapy using a four-hour ultra-rush induction scheme in bee and wasp allergy.
    Roll A; Hofbauer G; Ballmer-Weber BK; Schmid-Grendelmeier P
    J Investig Allergol Clin Immunol; 2006; 16(2):79-85. PubMed ID: 16689180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Safety Profiles of 3 Different Hymenoptera Venom Immunotherapy Protocols: A Retrospective 2-Center Study of 143 Patients.
    Pospischil IM; Kagerer M; Cozzio A; Angelova-Fischer I; Guenova E; Ballmer-Weber B; Hoetzenecker W
    Int Arch Allergy Immunol; 2020; 181(10):783-789. PubMed ID: 32781451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Honeybee and wasp venom allergy: Sensitization and immunotherapy.
    Adib-Tezer H; Bayerl C
    J Dtsch Dermatol Ges; 2018 Oct; 16(10):1228-1247. PubMed ID: 30300499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insect-sting challenge in 324 subjects with a previous anaphylactic reaction: current criteria for insect-venom hypersensitivity do not predict the occurrence and the severity of anaphylaxis.
    van der Linden PW; Hack CE; Struyvenberg A; van der Zwan JK
    J Allergy Clin Immunol; 1994 Aug; 94(2 Pt 1):151-9. PubMed ID: 8064067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of Hymenoptera venom allergy in Eastern Spain.
    Fernandez J; Soriano V; Mayorga L; Mayor M
    Clin Exp Allergy; 2005 Feb; 35(2):179-85. PubMed ID: 15725189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and clinical relevance of specific immunoglobulin E to pollen caused by sting- induced specific immunoglobulin E to cross-reacting carbohydrate determinants in Hymenoptera venoms.
    Kochuyt AM; Van Hoeyveld EM; Stevens EA
    Clin Exp Allergy; 2005 Apr; 35(4):441-7. PubMed ID: 15836751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bee and wasp venom allergy in Turkey.
    Kalyoncu AF; Demir AU; Ozcan U; Ozkuyumcu C; Sahin AA; Bariş YI
    Ann Allergy Asthma Immunol; 1997 Apr; 78(4):408-12. PubMed ID: 9109709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Emergency checklist: reactions to insect venom].
    Füessl HS
    MMW Fortschr Med; 2006 Jul; 148(29-30):34. PubMed ID: 16910405
    [No Abstract]   [Full Text] [Related]  

  • 12. Outcome survey of insect venom allergic patients with venom immunotherapy in a rural population.
    Roesch A; Boerzsoenyi J; Babilas P; Landthaler M; Szeimies RM
    J Dtsch Dermatol Ges; 2008 Apr; 6(4):292-7. PubMed ID: 18042250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hymenoptera sting anaphylaxis: detection and clinical significance of individual bee and wasp venoms specific IgE and IgG4 antibodies.
    Ameno S; Ameno K; Fuke C; Shinohara T; Kiriu T; Kinoshita H; Ijiri I
    Nihon Hoigaku Zasshi; 1993 Jun; 47(3):207-12. PubMed ID: 8345683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hymenoptera venom allergy.
    Przybilla B; Ruëff F
    J Dtsch Dermatol Ges; 2010 Feb; 8(2):114-27; quiz 128-30. PubMed ID: 19751222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of hymenoptera venom immunotherapy: a systematic review.
    Incorvaia C; Frati F; Dell'Albani I; Robino A; Cattaneo E; Mauro M; David M; Qualizza R; Pastorello E
    Expert Opin Pharmacother; 2011 Nov; 12(16):2527-32. PubMed ID: 21883032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term protection after stopping venom immunotherapy: results of re-stings in 200 patients.
    Lerch E; Müller UR
    J Allergy Clin Immunol; 1998 May; 101(5):606-12. PubMed ID: 9600496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anaphylaxis to hymenoptera sting: study of 113 patients].
    Pérez-Pimiento AJ; González-Sánchez LA; Prieto-Lastra L; Rodríguez-Cabreros MI; Iglesias-Cadarso A; Rodríguez-Mosquera M
    Med Clin (Barc); 2005 Oct; 125(11):417-20. PubMed ID: 16216188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of immunotherapy with venom in children with allergy to insect stings.
    Valentine MD; Schuberth KC; Kagey-Sobotka A; Graft DF; Kwiterovich KA; Szklo M; Lichtenstein LM
    N Engl J Med; 1990 Dec; 323(23):1601-3. PubMed ID: 2098016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simplification of intradermal skin testing in Hymenoptera venom allergic children.
    Cichocka-Jarosz E; Stobiecki M; Brzyski P; Rogatko I; Nittner-Marszalska M; Sztefko K; Czarnobilska E; Lis G; Nowak-Węgrzyn A
    Ann Allergy Asthma Immunol; 2017 Mar; 118(3):326-332. PubMed ID: 27986410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double sensitization to honeybee and wasp venom: immunotherapy with one or with both venoms? Value of FEIA inhibition for the identification of the cross-reacting ige antibodies in double-sensitized patients to honeybee and wasp venom.
    Straumann F; Bucher C; Wüthrich B
    Int Arch Allergy Immunol; 2000 Nov; 123(3):268-74. PubMed ID: 11112864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.